Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Richard

Showing results (771-780 of 781) with videos related to

Pageof 79
Sort By:
European Journal of Pain (London, England)|March 27, 2018
Efficacy and safety of a T-type calcium channel blocker in patients with neuropathic pain: A proof-of-concept, randomized, double-blind and controlled trialN Kerckhove, B Pereira, S Soriot-Thomas, et al.
Conservation Biology : the Journal of the Society for Conservation Biology|November 9, 2019
Effects of Natura 2000 on nontarget bird and butterfly species based on citizen science dataV Pellissier, R Schmucki, G Pe'er, et al.
The Lancet. Infectious Diseases|September 12, 2024
Health outcomes 3 months and 6 months after molnupiravir treatment for COVID-19 for people at higher risk in the community (PANORAMIC): a randomised controlled trialVictoria Harris, Jane Holmes, Oghenekome Gbinigie-Thompson, et al.
Nature Communications|February 23, 2024
Randomized controlled trial of molnupiravir SARS-CoV-2 viral and antibody response in at-risk adult outpatientsJoseph F Standing, Laura Buggiotti, Jose Afonso Guerra-Assuncao, et al.
Plos Medicine|September 26, 2019
Estimated stroke risk, yield, and number needed to screen for atrial fibrillation detected through single time screening: a multicountry patient-level meta-analysis of 141,220 screened individualsNicole Lowres, Jake Olivier, Tze-Fan Chao, et al.
The New England Journal of Medicine|April 22, 2026
Oral Nirmatrelvir-Ritonavir for Covid-19 in Higher-Risk OutpatientsChristopher C Butler, Andrew D Pinto, Victoria Harris, et al.
Circulation|November 26, 2019
Searching for Atrial Fibrillation Poststroke: A White Paper of the AF-SCREEN International CollaborationRenate B Schnabel, Karl Georg Haeusler, Jeffrey S Healey, et al.
Lancet (London, England)|December 25, 2022
Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trialChristopher C Butler, F D Richard Hobbs, Oghenekome A Gbinigie, et al.
ESC Heart Failure|February 4, 2025
Assessment of frailty in patients with heart failure: A new Heart Failure Frailty Score developed by Delphi consensusCristiana Vitale, Emmanuelle Berthelot, Andrew J S Coats, et al.
European Heart Journal|August 28, 2025
Recent-onset atrial fibrillation: challenges and opportunitiesEmma Svennberg, Ben Freedman, Jason G Andrade, et al.
Pageof 79

Showing results (771-780 of 781) with videos related to

Sort By:
Pageof 79
European Journal of Pain (London, England)|March 27, 2018
Efficacy and safety of a T-type calcium channel blocker in patients with neuropathic pain: A proof-of-concept, randomized, double-blind and controlled trialN Kerckhove, B Pereira, S Soriot-Thomas, et al.
Conservation Biology : the Journal of the Society for Conservation Biology|November 9, 2019
Effects of Natura 2000 on nontarget bird and butterfly species based on citizen science dataV Pellissier, R Schmucki, G Pe'er, et al.
The Lancet. Infectious Diseases|September 12, 2024
Health outcomes 3 months and 6 months after molnupiravir treatment for COVID-19 for people at higher risk in the community (PANORAMIC): a randomised controlled trialVictoria Harris, Jane Holmes, Oghenekome Gbinigie-Thompson, et al.
Nature Communications|February 23, 2024
Randomized controlled trial of molnupiravir SARS-CoV-2 viral and antibody response in at-risk adult outpatientsJoseph F Standing, Laura Buggiotti, Jose Afonso Guerra-Assuncao, et al.
Plos Medicine|September 26, 2019
Estimated stroke risk, yield, and number needed to screen for atrial fibrillation detected through single time screening: a multicountry patient-level meta-analysis of 141,220 screened individualsNicole Lowres, Jake Olivier, Tze-Fan Chao, et al.
The New England Journal of Medicine|April 22, 2026
Oral Nirmatrelvir-Ritonavir for Covid-19 in Higher-Risk OutpatientsChristopher C Butler, Andrew D Pinto, Victoria Harris, et al.
Circulation|November 26, 2019
Searching for Atrial Fibrillation Poststroke: A White Paper of the AF-SCREEN International CollaborationRenate B Schnabel, Karl Georg Haeusler, Jeffrey S Healey, et al.
Lancet (London, England)|December 25, 2022
Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trialChristopher C Butler, F D Richard Hobbs, Oghenekome A Gbinigie, et al.
ESC Heart Failure|February 4, 2025
Assessment of frailty in patients with heart failure: A new Heart Failure Frailty Score developed by Delphi consensusCristiana Vitale, Emmanuelle Berthelot, Andrew J S Coats, et al.
European Heart Journal|August 28, 2025
Recent-onset atrial fibrillation: challenges and opportunitiesEmma Svennberg, Ben Freedman, Jason G Andrade, et al.
Pageof 79